Scalp Hair Estradiol and Progesterone Level Determination in Women (Proof of Concept Study)
1 other identifier
observational
40
1 country
1
Brief Summary
The investigators hypothesis is that we can determine estrogen and progesterone levels in the hair by using the immune method and we can show a significant difference in the levels of these hormones in both groups of women: pre- and postmenopausal women. If indeed it would then be possible in future to carry out research that can find a relationship between the levels of these hormones and various diseases
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 19, 2016
CompletedFirst Posted
Study publicly available on registry
April 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedApril 28, 2016
April 1, 2016
10 months
April 19, 2016
April 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
concentration of hair scalp progesterone
concentration of hair scalp progesterone (nmol\\L)
3 months
concentration of hair scalp estrogen
concentration of hair scalp estrogen (pmol\\L)
3 months
Study Arms (1)
premenopausal and postmenopausal women
One group will include 20 premenopausal women under the age 40 years old, with regular menstruation cycles and without any illness or medication including birth control pills or steroidal ointments, and without known diagnosis of polycystic ovaries or fertility disorder. The second group will include 20 postmenopausal women over the age of 60, with no menstruation at least for the last five years, and without hormone therapy or treatment of any Steroidal therapy for the last year.
Eligibility Criteria
One group will include 20 women under the age 40 years old, with regular menstruation cycles and without any illness or medication including birth control pills or steroidal ointments, and without known diagnosis of polycystic ovaries or fertility disorder. The second group will include 20 women over the age of 60, with no menstruation at least for the last five years, and without hormone therapy or treatment of any Steroidal therapy for the last year.
You may qualify if:
- women under 40 with regular cycles
- Women over the age of 60 in menopause for at least 5 years
You may not qualify if:
- pregnant women
- oral contraceptive treatment in the last year
- hormonal replacement therapy in the last year
- month after delivery
- infertile women
- irregular menstruation
- women with progesterone secretion intrauterine device in the last year
- BMI- Body Mass Index- below 25 or above 35
- Polycystic Ovarian Syndrome
- steriodal treatment including inhalers and ointments.
- status post Removal of the ovaries or uterus
- Breast or uterine cancer in the past.
- any pituitary or adrenal disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samer Khoury
Haifa, 31048, Israel
Biospecimen
Scalp Hair
Study Officials
- PRINCIPAL INVESTIGATOR
samer khoury
Bnai Zion Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
April 19, 2016
First Posted
April 28, 2016
Study Start
March 1, 2016
Primary Completion
January 1, 2017
Study Completion
March 1, 2017
Last Updated
April 28, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share